You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
君實生物-B(01877.HK):暫停在新三板轉讓 相關事項正在有序推進中
格隆匯 02-12 18:16

格隆匯2月12日丨君實生物-B(01877.HK)發佈公告,君實生物(833330)擬首次公開發行股票並上市,根據有關規定,經公司向全國中小企業股份轉讓系統有限公司申請,公司於2019年9月24日在全國中小企業股份轉讓系統指定信息披露平台發佈了《關於申請股票首次公開發行並上市進展暨停牌公告》(公告編號:2019-123),公司股票自2019年9月25日起在全國中小企業股份轉讓系統暫停轉讓。

2020年1月6日,公司收到了上交所出具的上證科審(審核)[2020]7號《關於上海君實生物醫藥科技股份有限公司首次公開發行股票並在科創板上市申請文件的第二輪審核問詢函》。目前,公司首次公開發行股票並在科創板上市申請的審核狀態為“中止(財報更新)”。

目前,相關事項正在有序推進中,公司將根據相關事項進展情況嚴格按照法律法規的規定和要求,及時履行信息披露義務。公司H股在聯交所的買賣將不受影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account